Amazon Web Services (AWS) has announced a $4 billion investment in Anthropic, making AWS the primary cloud provider and ...

PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...

Scientists examine the effectiveness of an antibody targeting cell adhesion molecule 1 in alleviating pain-induced neuronal ...

WARREN, NJ, USA I6, 2024 I PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the global Phase 2 placebo-controlled CardinALS study did not meet its primary endpoint of slowing disease ...

Researchers from the Vanderbilt University School of Medicine Basic Sciences have uncovered the first example of ...

A large, retrospective analysis of patients with amyotrophic lateral sclerosis (ALS) and progressive muscular atrophy (PMA) indicates that a substantial proportion of PMA patients develop upper ...

Amazon is doubling its investment in Anthropic. The e-commerce giant will provide Anthropic with an additional $4 billion in ...

The locus coeruleus was found to facilitate the transition between NREM and REM sleep states while maintaining an unconscious ...

The cloud giant just launched another assault on Nvidia's lead in the AI chip market.

Discovery hints at wide-ranging potential for enhancing brain function Although it is widely recognized that sleep boosts ...

PTC Therapeutics' Phase II trial for utreloxastat in ALS failed to meet its primary endpoint, showing no significant ...

Wendy Williams' battle with dementia sparks debates on ethical storytelling, urging marketers to balance creativity, consent ...